Saturday 7 November 2026 Export TSHA’s income statement to Excel — free account

Taysha Gene Therapies, Inc.

Taysha Gene Therapies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.8 million, up 17.3% from fiscal 2024.

Revenue: +206.8%
EPS: −44.4%
Free cash flow: −100.3%
Total debt: +20.0%

Quarter to June 2026, against a year earlier

4.35 0.26 +6.36%

Follow TSHA

Alert me

Market cap: $1.3B
P/E: 0.0×
Fwd P/E: −8.5×
Dividend yield: —
F-score: 4/9
Altman Z: 8.05
Beneish M: n/a
Dividend safety: n/a

Overview

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	—	4	—	—
ROE Full definition →		(64.93%)	(68.45%)	(97.28%)	(47.05%)
ROA Full definition →		(40.23%)	(43.28%)	(59.21%)	(37.23%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(35.93%)	(35.76%)	(48.35%)	(34.17%)
Average Days of Receivables Full definition →		—	0.00	—	—
Free Cash Flow per Share Full definition →		(0.24)	(0.29)	(0.32)	(0.38)
Free Cash Flow Full definition →		(85.16)	(93.83)	(118.83)	(139.07)
Capital Expenditures Full definition →		(0.49)	(0.74)	(6.88)	(6.88)
Other line items
Cash ROIC Full definition →		(15.00%)	(15.20%)	(22.09%)	(15.59%)
Accounts Receivable Turnover Full definition →		—	0.00	—	—
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		0.00%	732.54%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		0.00%	287.14%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →		0.00%	112.74%	0.00%	0.00%
Interest Coverage Full definition →		(1,399.04)	(1,753.94)	(2,501.19)	(3,646.64)
Operating CF/Net income Full definition →		0.85	0.85	0.86	0.88
Depreciation/Fixed assets Full definition →		0.17	0.17	0.18	0.49
Capex/Depreciation Full definition →		(0.42)	(0.64)	(5.95)	(5.88)
Revenue per Share Full definition →		0.00	0.04	0.00	0.00
Operating CF per Share Full definition →		(0.24)	(0.29)	(0.31)	(0.36)
Capex per Share Full definition →		0.00	0.00	(0.02)	(0.02)
Capex to Sales Full definition →		0.00	0.06	0.00	0.00

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026

Stockrow Weekly